Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
about
Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasisDrugs for treating urinary schistosomiasisRepurposing drugs for the treatment and control of helminth infectionsMechanically produced schistosomula as a higher-throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trendsEfficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: exploratory phase-2 trialsAntischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoniEfficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobiumOrally active antischistosomal early leads identified from the open access malaria boxPraziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trialClinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trialsIn vitro effects of amodiaquine on paired Schistosoma mansoni adult worms at concentrations of less than 5 µg/mLNovel antipathy for schistosomiasis-the most lethal ailment of the tropical region.Neuroschistosomiasis.Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine.Effect of schistosomiasis and soil-transmitted helminth infections on physical fitness of school children in Côte d'Ivoire.Pathogen-driven cancers and emerging immune therapeutic strategies.Comparison of the in vitro Effects of One-day Exposure to Amodiaquine and Praziquantel on Schistosoma mansoni Adult Worm Pairs.In vitro and in vivo antischistosomal activity of ferroquine derivatives.Schistosomiasis chemotherapy.Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies.Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt.Prevention and control of schistosomiasis: a current perspective.In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.Diagnosis and management of schistosomiasis.Antischistosomal activities of mefloquine-related arylmethanols.In vitro and in vivo activity of 3-alkoxy-1,2-dioxolanes against Schistosoma mansoni.All that is blood is not schistosomiasis: experiences with reagent strip testing for urogenital schistosomiasis with special consideration to very-low prevalence settingsMapping malaria risk among children in Côte d'Ivoire using Bayesian geo-statistical modelsDynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged childrenTherapeutic effect of mefloquine on Schistosoma mansoni in experimental infection in miceDisposition of mefloquine and enpiroline is highly influenced by a chronic Schistosoma mansoni infection.The epidemiology of polyparasitism and implications for morbidity in two rural communities of Côte d'IvoireThe role of artesunate for the treatment of urinary schistosomiasis in schoolchildren: a systematic review and meta-analysis.Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?Novel carbazole aminoalcohols as inhibitors of β-hematin formation: Antiplasmodial and antischistosomal activities.Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis.Diagnosis and treatment of schistosomiasis in children in the era of intensified control.Parasitic diseases in travelers: a focus on therapy.Natural products as leads in schistosome drug discovery.The acceptability and safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and soil-transmitted helminthiasis in children aged 1-4 years in Uganda.
P2860
Q21560762-BAC5D08A-5AC8-43AB-BBAA-53F2633A060CQ24194447-5D8F86B7-FFA6-464C-ACC1-986E6F53D68FQ26823355-2B9380AC-F39D-491F-B9AF-9367D9F8D7D9Q28071848-48B29BD8-B8C6-43E7-A2EF-8801B0AF6B9BQ28476800-40B991AF-F7FB-4551-82E8-6E766DC9613FQ28480620-C4FF0797-50D1-430F-B595-028AAFD74711Q28484235-C5A90F8B-B3E4-4A4F-95D5-B8EF801B23D2Q28538566-AEF9A44D-36DA-43F5-B4B0-F559130B6147Q28540831-25C14B51-7A10-42AA-BF25-01591F805929Q28545079-4A5ECDBB-8B34-4D36-8300-DFBA3D8C2CC6Q31115153-B303B58E-4DD9-4101-80FC-9DD51E2C23E9Q33628987-7A4A1F31-A76D-4817-AFF6-34CC96FCD973Q33745561-4CD645DE-83BD-4DB7-A42A-6A0DD31B314DQ33892018-F66FDA7F-EA29-4A4B-A9DA-D3A9F630E117Q33980150-244BE8AC-475B-4C04-8BC2-C8CA9AAC3FB1Q34054175-D8F836E1-5A95-4DDA-855E-B518828F40AAQ34071489-BD96D7A8-BB8E-4147-8C75-23306D565AF3Q34185025-73F461D1-168D-4DE7-8BAA-7F02D8862E61Q34354490-C43D3E09-F8E5-4C3D-925A-99671C5936C6Q34366867-043797E0-6C25-4B30-8013-E513B3C2AA6CQ34496255-63A6E29C-31C4-4BDF-A692-6E46F5CB4BD8Q34510660-9145FA28-CD18-4761-9DF9-D20D5B5A41DFQ34529138-4FFC4EF3-D4A4-4B9B-A2A6-F71F528643D5Q35590947-43D779C2-9316-4C49-8414-7FAF8AD99FF5Q36018841-D54FBE32-485C-4DFA-BD23-B48682943533Q36088768-6CB2AE6B-F90F-4100-BF62-89C41279B275Q36270500-0E19E1F5-E3A7-4E98-8BD9-45D86C1D3B9DQ36353872-899C5337-1828-4960-A19D-E02FB614D743Q36572029-32BD430F-01DC-4BFC-B401-E7E885D75ADDQ37053148-6016ACCB-AA2D-465D-965C-4B23B950F8C8Q37124226-F9FD39FF-4170-4191-BB53-9EBCA764D81DQ37616968-87CBF4FA-3394-4EE2-A4DD-5F2400253691Q37726847-C7370BB4-12F3-431C-9F42-EEB0874B0714Q37726920-DD699A9C-2C38-4F55-8997-783294DA54E2Q37742177-2F363ABC-3693-4E86-9CFD-566E018AD6E4Q38123553-81406C92-39FD-4E9B-8DFE-06B3E98364CCQ38152776-AB4D7DF6-D33C-4C31-9DBF-CAD023D3C483Q38192001-81D2C572-2B74-4AB0-9C4F-6A61F6095998Q38334179-5FB4AD09-607A-4212-8C14-1A45D0F35E4CQ38870767-E23754F3-98CA-466C-80CF-DD4FEEC8F475
P2860
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Efficacy and safety of mefloqu ...... exploratory open-label trial.
@en
type
label
Efficacy and safety of mefloqu ...... exploratory open-label trial.
@en
prefLabel
Efficacy and safety of mefloqu ...... exploratory open-label trial.
@en
P2093
P50
P921
P356
P1476
Efficacy and safety of mefloqu ...... exploratory open-label trial.
@en
P2093
Kigbafori D Silué
Koffi D Adoubryn
Nicaise A N'Guessan
P304
P356
10.1086/651682
P407
P5008
P577
2010-05-01T00:00:00Z